MRUS Merus Corp: Rasio Kapitalisasi Pasar marang Nilai Buku

Merus Corp (MRUS) - logo korporat

As Merus N.V. (MRUS) is currently in the clinical testing phase, it does not yet possess the market leverage to establish premium pricing. The current price action shown below is accompanied by the 8.84 indicator. The business focuses on developing multi-specific drugs for the targeted destruction of neoplasms. Meanwhile, the company minimizes financial risks by licensing its proprietary developments to industry behemoths through long-term contracts.

Merus N.V. (MRUS) - Rasio Kapitalisasi Pasar marang Nilai Buku saka 04.07.2022 nganti 10.01.2026

MRUS (Merus NV): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
Bagan rega Merus N.V.|MRUS - Target median analis
- data kapitalisasi pasar:
Kapitalisasi pasar Merus Corp|MRUS - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data kapitalisasi buku:
Nilai Buku saben Saham Merus|MRUS - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku merus.nl|MRUS - Total Aset Bisnis
- data utang lan likuiditas:
Total Utang marang Modal Merus N.V.|MRUS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Merus Corp|MRUS - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Merus Corp
Pambiji fundamental:MRUS (Merus N.V.)
Produk dadi Merus NV

This indicator measures the degree of market optimism by comparing the current stock value with the company's actual book assets. Analyzing the trend of the market-to-book ratio reveals that the 8.84 value reflects a speculative premium on the capital of Merus N.V. (MRUS), which is supported by significant liquidity and strategic financing during the clinical trial stage.

Pesaing utama

Immutep Limited - Rasio Nilai Pasar marang Nilai Buku|anixa.com (ANIX) - Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ATOS|Rasio Kapitalisasi marang Aset Bersih Context Tx|Rasio Kapitalisasi Pasar marang Nilai Buku MRSN|Rasio Kapitalisasi Pasar marang Nilai Buku BCTX (BriaCell Corp)|EPIX - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku qtimaging.com QTI